RESMED INC — Director's Dealing 2021

Aug 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-08-19

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-19	ResMed Common Stock	A	18418	—	Acquired	424611	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	8970	Indirect

Footnotes

F1: Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on August 19, 2021, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.

F2: Includes 33.4591 shares of ResMed stock purchased on April 30, 2021, through the ResMed Employee Stock Purchase Plan.